1302 — LifeTech Scientific Cashflow Statement
0.000.00%
Last trade - 00:00- HK$7.36bn
- HK$6.65bn
- CNY1.27bn
- 70
- 31
- 13
- 27
Annual cashflow statement for LifeTech Scientific, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 171 | 243 | 333 | 378 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 119 | 16.2 | -3.9 | 86.1 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -64.2 | 22.7 | 55.7 | -136 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 275 | 339 | 441 | 388 | — |
| Capital Expenditures | -102 | -105 | -276 | -226 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -154 | -237 | 237 | -232 | — |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -256 | -342 | -39 | -458 | — |
| Financing Cash Flow Items | -10.1 | -10.2 | 14.7 | 0.158 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -72.6 | 675 | -256 | -215 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -53.5 | 673 | 148 | -285 | — |